Using AI to determine optimal cost-effective diagnostic pathways for chronic breathlessness
(2026) In npj Primary Care Respiratory Medicine 36(1).- Abstract
Breathlessness is a common symptom in clinical practice, yet evidence for cost-effective strategies to diagnose the underlying health conditions causing breathlessness remains limited. Using Swedish population data with individuals with moderate to severe breathlessness, we developed an artificial intelligence (AI) reinforcement learning model to identify optimal, low-cost diagnostic pathways for breathlessness tailored to subgroups based on sex and smoking exposure. Sixteen clinically relevant conditions were defined, along with their diagnostic tests and standard healthcare costs. The AI-based approach successfully produced efficient and low-cost diagnostic pathways for breathlessness with high diagnostic yield. The optimal sequences... (More)
Breathlessness is a common symptom in clinical practice, yet evidence for cost-effective strategies to diagnose the underlying health conditions causing breathlessness remains limited. Using Swedish population data with individuals with moderate to severe breathlessness, we developed an artificial intelligence (AI) reinforcement learning model to identify optimal, low-cost diagnostic pathways for breathlessness tailored to subgroups based on sex and smoking exposure. Sixteen clinically relevant conditions were defined, along with their diagnostic tests and standard healthcare costs. The AI-based approach successfully produced efficient and low-cost diagnostic pathways for breathlessness with high diagnostic yield. The optimal sequences were overall similar between the subgroups. For all participant subgroups, the AI-derived pathways initially identified (or order of effectiveness in relation to costs) clinical evaluations of body mass index, anxiety and depression, physical activity levels, and spirometry. Subsequent steps included diffusing capacity measurements, chest computer tomography, and hemoglobin assessment. Overall, investigations of the lungs were prioritized ahead of investigations of the heart. This strategy has the potential to streamline the evaluation of breathlessness, reduce unnecessary testing, lead to an earlier diagnosis at lower cost, and support more targeted clinical management.
(Less)
- author
- organization
-
- Breathlessness and chronic respiratory failure (research group)
- EpiHealth: Epidemiology for Health
- Respiratory Medicine, Allergology, and Palliative Medicine
- Cell Death, Lysosomes and Artificial Intelligence (research group)
- LTH Profile Area: AI and Digitalization
- LTH Profile Area: Engineering Health
- LU Profile Area: Natural and Artificial Cognition
- ELLIIT: the Linköping-Lund initiative on IT and mobile communication
- LTH Profile Area: Aerosols
- Clinical Physiology and Nuclear Medicine, Malmö (research group)
- Cardiovascular Research - Epidemiology (research group)
- Department of Earth and Environmental Sciences (MGeo)
- Electrocardiology Research Group - CIEL (research group)
- Centre for Environmental and Climate Science (CEC)
- The Institute for Palliative Care (research group)
- publishing date
- 2026-08-13
- type
- Contribution to journal
- publication status
- published
- subject
- keywords
- Humans, Dyspnea/diagnosis, Cost-Benefit Analysis, Artificial Intelligence, Female, Cost-Effectiveness Analysis, Male, Chronic Disease, Sweden, Middle Aged, Spirometry
- in
- npj Primary Care Respiratory Medicine
- volume
- 36
- issue
- 1
- article number
- 57
- publisher
- Nature Publishing Group
- external identifiers
-
- pmid:42595763
- ISSN
- 2055-1010
- DOI
- 10.1038/s41533-026-00548-9
- language
- English
- LU publication?
- yes
- additional info
- © 2026. The Author(s).
- id
- 19590150-2b29-4824-aef4-69e66e5d7ba1
- date added to LUP
- 2026-08-17 09:11:53
- date last changed
- 2026-08-17 15:30:37
@article{19590150-2b29-4824-aef4-69e66e5d7ba1,
abstract = {{<p>Breathlessness is a common symptom in clinical practice, yet evidence for cost-effective strategies to diagnose the underlying health conditions causing breathlessness remains limited. Using Swedish population data with individuals with moderate to severe breathlessness, we developed an artificial intelligence (AI) reinforcement learning model to identify optimal, low-cost diagnostic pathways for breathlessness tailored to subgroups based on sex and smoking exposure. Sixteen clinically relevant conditions were defined, along with their diagnostic tests and standard healthcare costs. The AI-based approach successfully produced efficient and low-cost diagnostic pathways for breathlessness with high diagnostic yield. The optimal sequences were overall similar between the subgroups. For all participant subgroups, the AI-derived pathways initially identified (or order of effectiveness in relation to costs) clinical evaluations of body mass index, anxiety and depression, physical activity levels, and spirometry. Subsequent steps included diffusing capacity measurements, chest computer tomography, and hemoglobin assessment. Overall, investigations of the lungs were prioritized ahead of investigations of the heart. This strategy has the potential to streamline the evaluation of breathlessness, reduce unnecessary testing, lead to an earlier diagnosis at lower cost, and support more targeted clinical management.</p>}},
author = {{Olsson, Max and Ahmed, Rafsan and Ekstrand, Joakim and Blomberg, Anders and Jernberg, Tomas and Börjesson, Mats and Evans, Rachael A and Malinovschi, Andrei and Sandberg, Jacob and Sköld, Magnus and Wollmer, Per and Östgren, Carl Johan and Engström, Gunnar and Björkelund, Anders J and Ekström, Magnus}},
issn = {{2055-1010}},
keywords = {{Humans; Dyspnea/diagnosis; Cost-Benefit Analysis; Artificial Intelligence; Female; Cost-Effectiveness Analysis; Male; Chronic Disease; Sweden; Middle Aged; Spirometry}},
language = {{eng}},
month = {{08}},
number = {{1}},
publisher = {{Nature Publishing Group}},
series = {{npj Primary Care Respiratory Medicine}},
title = {{Using AI to determine optimal cost-effective diagnostic pathways for chronic breathlessness}},
url = {{http://dx.doi.org/10.1038/s41533-026-00548-9}},
doi = {{10.1038/s41533-026-00548-9}},
volume = {{36}},
year = {{2026}},
}
